{
  "title": "Scientists Are Gaining On RSV, a Persistent Threat to Children",
  "link": "https://www.nytimes.com/2022/11/01/health/rsv-children-vaccines.html",
  "guid": "https://www.nytimes.com/2022/11/01/health/rsv-children-vaccines.html",
  "atom:link": "",
  "description": "Vaccines and treatments are in trials, but the virus remains a leading killer of infants worldwide.",
  "dc:creator": "Apoorva Mandavilli",
  "pubDate": "Tue, 01 Nov 2022 13:11:18 +0000",
  "category": [
    "your-feed-science",
    "Vaccination and Immunization",
    "Respiratory Syncytial Virus (RSV)",
    "Babies and Infants",
    "Children and Childhood",
    "Respiratory Diseases",
    "Infant Mortality",
    "Pfizer Inc",
    "GlaxoSmithKline PLC"
  ],
  "media:content": "",
  "media:credit": "Marijan Murat/Picture Alliance, via Getty Images",
  "media:description": "An intensive care nurse caring for a child suffering from respiratory syncytial virus in Stuttgart, Germany, last year."
}